CLINICAL_TRIALS
trial_result
· 2021-02-16
Clinical Trial Update: Analgesic Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) for Central Neuropathic Pain in Multiple Sclerosis [Phase 3]
Summary
Phase 3 clinical trial assessing repetitive transcranial magnetic stimulation (rTMS) for central neuropathic pain in multiple sclerosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Hospital, Clermont-Ferrand | Conditions: Multiple Sclerosis With Central Neuropathic Pain | Phase 3 | Status: UNKNOWN